Quercetin exhibits anti-therapeutic effects in preclinical models through suppression of IgE, modulation of immune cells, and rebalancing of Th1/Th2 cytokines, indicating its potential for use as an adjunct therapy for allergic diseases. This evidence concerns the gene IGHE and allergic disease.